Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease is a research paper published in Cells (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Michael J. Fox Foundation
Grant: MJFF13558
NIH HD
Grant: R21 HD102788
National Institutes of Health
Grant: 5R21HD102788-02
Brain organoid modeling of Gaucher disease for identification of pathogenic pathways and therapy development
National Institutes of Health
Grant: 1UH2NS092981-01
The Development of Small Molecule Inhibitors for Gaucher Disease Type 3
National Institutes of Health
Grant: 5R01NS086134-02
Gaucher disease:Treatment of neurodegenerative disease
National Institutes of Health
Grant: 5R01NS103931-03
Progranulin: A Novel Gene in Gaucher Diseases
NINDS NIH HHS
Grant: R01 NS103931
NIH HHS
Grant: R21 OD033660
NINDS NIH HHS
Grant: R01 NS086134
NINDS NIH HHS
Grant: UH2 NS092981
NIAMS NIH HHS
Grant: R01 AR061484
FWCI
1.26
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals